MedTrace Logo

Clinical Validation Protocol for BCI for the Communication of Patients Suffering From Neuromuscular Disorders.

NCT02284022 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2017-04-20

No results posted yet for this study

Summary

the objective of this protocol is evaluate the safety and tolerance of a communication system for severely disable patients with myopathies. The system analyses the brain electric activity in real time and converts it into digital commands for a spelling device, which is refered to as the P300 speller in the scientific literature. The secondary objective is to compare the performance of such tool with a more traditional assistive technology for the communication of severely disabled patients : scanner systems.

Conditions

Interventions

DEVICE

Brain computer interface

Recording the P300 Testing the device Using the device with a speller

Sponsors & Collaborators

  • Association Française contre les Myopathies (AFM), Paris

    collaborator OTHER

  • Centre d'Investigation Clinique et Technologique 805

    lead OTHER

Principal Investigators

  • David Orlikowski, MDPhD · Assistance Publique - Hôpitaux de Paris

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2017-02-28
Completion
2017-02-28

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02284022 on ClinicalTrials.gov